Efficacy of noncarbapenem therapy for the treatment of ceftriaxone-resistant Enterobacterales outside the urinary tract.

Published in: Antimicrobial stewardship & healthcare epidemiology : ASHE (2024)

Noncarbapenem therapy may play a role for certain patients with infections caused by ESBL-producing organisms.

Keyphrases